Consolidated results for the first quarter of FY2027. Revenue is expected to increase year over year; disclosure of trends in domestic and international segment revenue. Key indicators by segment revenue, cost of sales, SG&A, operating income, ordinary income, and quarterly net income attributable to owners of parent are disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4540","jir_company_name":"Tsumura & Co.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4540-20260806-01.pdf","jir_short_summary":"Consolidated results for the first quarter of FY2027. Revenue is expected to increase year over year; disclosure of trends in domestic and international segment revenue. Key indicators by segment revenue, cost of sales, SG&A, operating income, ordinary income, and quarterly net income attributable to owners of parent are disclosed.","jir_summary":"### Section Heading\nThis quarter\u2019s results summary includes explanations of management performance, financial position, notes on the preparation of consolidated financial statements, and the trends in quarterly net income and segment information. Specific figures such as revenue and various expense items are available in the relevant tables of the PDF; this summary notes them as Unknown. Segment revenue and contributions from drug development cases, and the breakdown of Growing prescriptions are provided as notes.\n\n### Section 2 Heading\nThere is also coverage of cash flow related to the earnings, financial position, and outlook. The quarterly financial statements and notes include changes in cash and cash equivalents, breakdown of assets and liabilities, and components of net assets, with YoY comparisons. Future outlook details are limited within this document.","jir_financial_highlights":"Sales: Unknown (The change from the previous period is described in the text, but specific figures are unknown)\nCost of sales: Unknown (Unknown)\nSelling, general and administrative expenses: Unknown (Unknown)\nOperating income: Unknown (Unknown)\nOrdinary income: Unknown (Unknown)\nNet income attributable to owners of parent: Unknown (Unknown)","jir_category":"","jir_hashtags":"#Tsumura, #Earnings, #Case: Development Drug Prescriptions, #GrowingPrescriptions","jir_key_figures":"Sales: Unknown (no data in PDF)\nOperating income: Unknown\nOrdinary income: Unknown\nTotal net assets: Unknown","jir_meta_title":"\u3010Tsumura\u3011Q1 FY2027 Earnings Report\uff5cRevenue and Profit Trends Unknown","jir_meta_description":"Analysis of Tsumura's Q1 FY2027 earnings report. Key figures are listed as unknown in the PDF text. Organized highlights of segment trends and cash flow status.","jir_og_title":"Tsumura Q1 Earnings Report\uff5cRevenue and profit unknown","jir_og_description":"Summary of Tsumura's Q1 FY2027 earnings report. Key financial indicators are marked as unknown in the text, with a focus on segment information and cash flow.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":8172,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-96046","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n